Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
liquid biopsy
MedTech
Blood test powered by AI shows early promise in childhood cancer
A new liquid biopsy test using artificial intelligence models could help spot a rare type of bone and soft tissue cancer.
Ben Adams
Apr 27, 2026 10:00am
Guardant360-guided breast cancer therapy swaps boost survival
Jun 3, 2025 10:00am
PHASE Scientific raises $34M for urine-based diagnostic platform
May 21, 2025 11:15am
Eisai's abandoned Enhertu challenger set to live on at BlissBio
Mar 21, 2025 7:20am
JPM25: Guardant posts 31% sales gain as cancer blood tests grow
Jan 13, 2025 9:19am
Guardant awarded $292M in false advertising suit against Natera
Nov 26, 2024 10:45am
